Capital Allocation

The diagnostics firm has 180 days to boost its market value after a Nasdaq warning, placing immense pressure on its turnaround and high-stakes biosensor plans.

First Horizon's financial and credit chiefs will present at a key conference. We dive into their strategy amid industry headwinds and strong 2025 results.

As PBF Energy prepares for key investor conferences, all eyes are on its strategy for balancing traditional refining with its major renewable fuels venture.

With a major capital infusion, the biotech firm will accelerate its lead drug for Eosinophilic Esophagitis and expand its innovative Diffusphere™ platform.

Nutrien's leadership prepares for two major investor conferences, facing questions on fertilizer markets, critical minerals, and global food security.

Geneva's SwissChain Holding SA is tokenizing traditional equity, leveraging Switzerland's DLT Act to blend legacy finance with blockchain efficiency.

Backed by strong earnings, Jackson Financial boosts its shareholder payout, signaling confidence and a robust capital return strategy in the annuity market.

NCR Voyix expands its share repurchase program, signaling strong confidence while navigating a major business transformation and a competitive market.

After a costly regulatory exit, crypto giant Nexo plans a 2026 U.S. return, partnering with Bakkt in a bid to redefine compliant digital finance.

Think franchising is just buying a job or a famous name? Experts reveal the truth about systems, scalability, and making a smart investment.

Indian clean energy giant ReNew posts stellar results, slashing losses and boosting profits, thanks to its booming solar manufacturing division.

Panama finalizes its multi-billion dollar bond tender offer, a strategic move to refinance debt amid fiscal pressures and a changing economic landscape.

With top proxy firms ISS and Glass Lewis on board, Criteo's plan to redomicile and simplify its stock structure is a major play for U.S. investors.

Pharmaceutical giant Cencora locks in $3B in financing to pay down debt from its massive OneOncology acquisition, deepening its strategic bet on cancer care.

Enpro's 3.2% dividend hike reflects more than just stability; it's a sign of a successful growth strategy and robust health in key tech sectors.

Top policymakers, including Dr. Agustín Carstens and FATF President Luis Urrutia Corral, will convene in Mérida to address critical cross-border tax issues.

A new $500M fund aims to profit from the U.S. housing shortage by banking on its scarcest resource: land. But can it deliver for investors and builders?

Swedish mining giant Boliden lands a massive €1 billion credit line, signaling strong bank confidence and fueling its expansion after a landmark year.

A new SEC-registered transfer agent, OpenAgent, launches to bridge blockchain efficiency with institutional compliance, heralding a new era for digital assets.

The biotech firm enacts a 1-for-25 stock split to avoid delisting, placing its promising cancer therapy pipeline under a brighter, more critical spotlight.